Search Count: 10
 |
Crystal Structure Of The L7Ae Derivative Protein Ls4 In Complex With Its Co-Evolved Target Cs1 Rna
Organism: Archaeoglobus fulgidus (strain atcc 49558 / dsm 4304 / jcm 9628 / nbrc 100126 / vc-16), Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-04-02 Classification: RNA BINDING PROTEIN Ligands: MG |
 |
Crystal Structure Of The L7Ae Derivative Protein Ls12 In Complex With Its Co-Evolved Target Cs2 Rna
Organism: Archaeoglobus fulgidus (strain atcc 49558 / dsm 4304 / jcm 9628 / nbrc 100126 / vc-16), Synthetic construct
Method: X-RAY DIFFRACTION Resolution:3.12 Å Release Date: 2025-04-02 Classification: RNA BINDING PROTEIN Ligands: CA |
 |
Organism: Archaeoglobus fulgidus dsm 4304
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2025-04-02 Classification: RNA BINDING PROTEIN |
 |
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-01-22 Classification: DNA BINDING PROTEIN Ligands: FE2, NIO, PRO |
 |
 |
Discovery Of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(Trifluoromethoxy)Phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3-Dihydropyrido[2,3-B]Pyrazine-4(1H)-Carboxamide (Tak-915), A Highly Potent, Selective, And Brain-Penetrating Phosphodiesterase 2A Inhibitor For The Treatment Of Cognitive Disorders
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2017-12-27 Classification: Hydrolase/Hydrolase Inhibitor Ligands: ZN, MG, 9GA |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-04-13 Classification: HYDROLASE Ligands: CL, ACT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.54 Å Release Date: 2015-06-24 Classification: HYDROLASE Ligands: ZN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2012-10-03 Classification: HYDROLASE Ligands: ZN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2012-10-03 Classification: HYDROLASE Ligands: ZN, CL |